Lymphomatoid papulosis (LyP) belongs to the spectrum of primary cutaneous CD30-positive lymphoproliferative disorders. Clinically, LyP is characterized by a variable number of self-healing papulo-nodular lesions, with the typical waxing and waning course. Histologically, 4 types (A, B, C, and D) have been delineated. Angioinvasive growth and large ulcers are rare findings in LyP and simulate aggressive lymphoma. We retrospectively analyzed the clinicopathologic and molecular features of angioinvasive LyP in a series of 16 patients. This new form of LyP is characterized by oligolesional papules that rapidly ulcerate and evolve into large necrotic eschar-like lesions with a diameter of 1 to 4 cm and an angiocentric and angiodestructive infiltrate of small-sized to medium-sized atypical lymphocytes expressing CD30 and frequently CD8. As in other forms of LyP, the lesions underwent spontaneous regression after a few weeks. Recurrences were common, but the prognosis was excellent with no extracutaneous spread or disease-related deaths. Complete remission occurred in 9 of 16 patients (56%). This LyP variant should be distinguished from aggressive forms of angiocentric and angiodestructive and cytotoxic T-cell lymphomas. We propose the term LyP type E for this clinically and histologically unusual variant.
LyP types (A, B, C, and D) have been identified. Type A is characterized by the presence of large pleomorphic or anaplastic CD30 + T cells scattered or in small clusters within the background of eosinophilic and neutrophilic granulocytes, histiocytes, and small lymphocytes. Type B shows epidermotropic infiltrates of small-sized to medium-sized lymphoid cells, with variable extent of CD30 expression. In type C, a nodular dense infiltrate of cohesive sheets of pleomorphic or anaplastic CD30 + cells is present, and it usually contains only a few eosinophilic or neutrophilic granulocytes. [3] [4] [5] [6] [7] Recently, type D has been described, which displays an epidermotropic infiltrate of CD8 + and CD30 + small-sized to medium-sized lymphoid cells. 8 Within the same patient, different lesions may show different histologic types, either synchronously or metachronously. 9 The CD30 + lymphoid cells may express CD4, CD8, or CD56, with CD4 immunoreactivity being the most common phenotype. 10, 11 Independent of its histologic pattern and the immunophenotype, LyP is clinically characterized by a variable number of selfhealing papulo-nodular lesions, with the typical waxing and waning course. The individual lesions undergo spontaneous regression within a few weeks, sometimes accompanied by ulceration on top of the lesions and occasionally leaving behind varioliform scars. Despite the presence of medium-sized to large-sized pleomorphic or anaplastic cells suggesting a highly malignant course, LyP exhibits a favorable prognosis and requires no aggressive treatment. 2, 12, 13 We report a series of 16 patients with LyP who presented with a clinically and histologically unusual manifestation simulating highly aggressive angiocentric and angiodestructive T-cell lymphoma. These patients developed recurrent papular lesions that rapidly turned into hemorrhagic necrotic ulcers (eschar like) with a diameter of >1 cm and spontaneous regression, often leaving behind a scar. The typical features were rather large size of ulceration exceeding the size of the preexisting papule/nodule and presentation with only a few lesions at a given time. Histologically, predominantly angiocentric and angiodestructive infiltrates of CD30 + and mostly CD8 + lymphoid cells as well as necrotic areas were the hallmark. Remarkably, the skin lesions resolved spontaneously, and none of the patients manifested progressive disease with extracutaneous involvement or died of lymphoma, reflecting an indolent course with an excellent prognosis. With regard to the excellent prognosis it is important to differentiate this form of LyP from other angiocentric primary or secondary cutaneous T-cell lymphomas with an aggressive course and poor outcome.
PATIENTS AND METHODS
Since our first observation in the year 2000, we have identified 16 patients presenting with similar clinical and histologic features suggesting an unusual form of LyP. The diagnosis of LyP was based on recurrent skin lesions undergoing spontaneous regression, the presence of atypical lymphoid cells with expression of CD30, and a benign course of the disease. Excluded from the study were 5 additional patients with similar histopathologic features but clinical presentation with a solitary lesion.
A total of 21 biopsy specimens from the included 16 patients were collected and reviewed, including 18 skin biopsies and 3 specimens from the oral mucosa.
The main clinical data including history (age at first lesion/symptoms, age at diagnosis), morphology of skin lesions and their evolution, occurrence and number of relapses, and last follow-up, as well as results of staging examinations and treatment were retrieved from the referring dermatologists and from the patients' charts. In 8 of the 16 patients clinical images were available for review. Four patients were dermatologically examined by 1 of the authors (W.K.). Hematoxylin and eosin (H&E)stained slides and immunohistochemical stainings were analyzed and molecular biologic assays performed. The study was approved by the Ethical committee of the Kanton Zu¨rich, Switzerland (KEK-StV-No. 04/12).
Histology
All biopsies were fixed in 10% buffered formalin and embedded in paraffin. Hematoxylin and eosin-stained sections with a thickness of 4 mm were evaluated and the following findings reported:
Ulceration/excoriation of the epidermis (oral mucosa epithelium), epidermal (epithelial) hyperplasia, vacuolar alteration, edema in the papillary dermis, perivascular or diffuse pattern of the infiltrates, infiltration and destruction of vessel walls, intraluminal thrombi, size (small, medium, large) and morphology (pleomorphic, anaplastic) of lymphoid cells, presence of eosinophils and neutrophils, extension of the infiltrate into the subcutis, perineural or intaneural invasion, and adnexal involvement.
Immunohistochemistry
Immunohistochemical studies were performed on formalin-fixed paraffin-embedded tissue using the following antibodies: CD2 (1:50; Novocastra/Leica-Microsystems, Heerbrugg, Switzerland), CD3 (1:75; Dako, Glostrup, Denmark), CD4 (1:2; Novocastra/Leica-Microsystems), CD5 (1:2; 4C7; Dako), CD7 (1:25; Dako), CD8 (1:400; Dako), CD20 (1:600; Dako), CD30 (1:75; Novocastra/ Leica-Microsystems), CD45RA (1:100; X148; Novocastra), CD45RO (prediluted; UCHL1; Leica), CD56 (RTU; Novocastra/Leica-Microsystems), TIA (1:50; Immunotech, Marseille, France), T-cell receptor (TCR)-b F1 (8A3; 1:50; Thermo Scientific, Fremont, CA), TCR-g/d (y3.20; 1:100; Thermo Scientific), and CD246 (1:50; ALK-1; Dako). Appropriate positive controls were included. The number of antibodies used varied among individual cases depending on the available tissue. For all cases, a general predominance of CD4 + or CD8 + cells in the interstitial infiltrate and particular phenotype of cells in the perivascular and/or angioinvasive lymphocytes within the vessel walls were documented. For the latter, the results were assigned to 1 of the 4 categories: immunoreaction in all of the affected vessels (+); immunoreaction in a majority of the affected vessels (+/À); immunoreaction in a minority of the affected vessels (À /+); no immunoreaction in any of the affected vessels (À).
Molecular Biology
The cases were studied for rearrangement of TCR-g genes and for the presence of viral DNA of a variety of viruses including Orthopox, Parapox, Parvovirus B19, cytomegalovirus, Varicella zoster virus, Herpes simplex virus 1/2, and Epstein-Barr virus (EBV) in a single laboratory (Dermatopathology, Friedrichshafen, Germany). In addition, EBV-encoded small RNA in situ hybridization was performed (RTU; Novocastra/Leica-Microsystems). The detailed description of the technique for TCR gene rearrangements was described elsewhere. 14 In brief, the TCR clonality studies were performed using 3 multiplex polymerase chain reactions with different primers from the variable region in each reaction (reaction 1: Vg1 to 8; reaction 2: Vg9; and reaction 3: Vg10, Vg11, and Vg12) and the same Cy-5-labeled primers from the conserved region (JGP1/2, JG1/2, and JGP).
RESULTS

Clinical Presentation, Course of the Disease, Treatment, and Follow-up
The main clinical features are summarized in Table 1 . There was a male preponderance (men:women, 3:1) with 12 male and 4 female patients. The mean age at diagnosis was 51.7 years ranging from 8 to 77 years (median age, 61 y). All of them had several clinical features in common, which included occurrence of only a very few papulo-nodular lesions that rapidly evolve into larger ulcerations exceeding the size of the antecedent papule (diameter 1 to 4 cm). The lesions often manifested a hemorrhagic necrotic crust and had an eschar-like appearance, prompting clinical consideration of pyoderma gangrenosum, ulcerative herpes infection or Orf disease, or vasculitis. The ulcers usually persisted for 3 to 6 weeks before undergoing spontaneous regression, leaving behind a scar. Typically, only few ulcerative lesions (sometimes a single ulcer) were present at a given time, but the patients as a rule experienced several relapses ( Figs. 1, 2 ).
In addition to large ulcerative lesions, 4 patients (cases 2, 7, 12, and 16), at one point of the disease, manifested several (up to 10) smaller papules similar to those seen in classic LyP (Fig. 3 ). Three patients (cases 1, 10, and 15) showed involvement of the lips and/or oral mucosa at primary disease manifestation or during the course of the disease (Fig. 4) . In another 2 patients (cases 4 and 13), the primary lesions and the recurrences were limited to 1 body area corresponding to localized (regional) LyP. Because of suspected cutaneous lymphoma, 12 patients underwent staging investigations to exclude extracutaneous involvement with negative results. In regard to the indolent course and spontaneous resolution of lesions, no staging examinations were performed in 5 patients.
Only 3 patients received low-dose methotrexate subcutaneously (15 to 30 mg/wk), whereas all the others were treated with topical antiseptic or topical steroids or UV light therapy including heliotherapy, UVB narrow band, and psoralen UVA treatment. During follow-up, relapses occurred in all patients within 1 year. In none of the patients did the disease progress to involve ex-tracutaneous sites or cause death of the patient. Complete remission occurred in 9 of the 16 patients (56%) after a mean follow-up of 37.5 months (median, 24 mo; range, 3 to 144 mo).
Histopathologic Features
The consistent feature in all cases was dermal angiocentric infiltrates of small-sized, medium-sized, to large-sized pleomorphic cells that infiltrated the walls of small-sized to medium-sized dermal and subcutaneous blood vessels. The vessels involved included small arterioles and medium-sized veins located mostly in the dermis; however, in some cases in which the subcutaneous tissue was present, the affected vessels were seen in the subcutis (Figs. 5A, B, 6A, B). Usually, several vessels were involved in a given specimen, and many were completely destroyed, which probably accounted for necrosis of the adjacent dermis, overlying epidermis, and adnexal structures. Thrombosis of affected vessels was a feature in over half of the specimens. In addition to the vessels infiltrated and destroyed by the atypical lymphoid cells, there were vessels in the same specimens, which patient. Only in 1 small punch biopsy this characteristic feature was absent, but another specimen from the same patient displayed angioinvasive infiltrates.
Apart from atypical lymphocytes, most specimens revealed numerous eosinophilic granulocytes arranged interstitially in the dermis or subcutis, often forming small collections. Neutrophils were present too, but their estimation was hampered by necrosis and karyorrhexis. Other common features included epidermal (epithelial) necrosis and prominent edema in the papillary dermis.
In some cases there was focal epidermotropism and subtle folliculotropism of small lymphoid cells, but in 2 cases there were also medium-sized atypical cells within the epidermis, which expressed CD8 and CD30 (vide infra) Am J Surg Pathol Volume 37, Number 1, January 2013
Angioinvasive Lymphomatoid Papulosis (Figs. 7A-C). In cases in which the vessels in the subcutis were involved, there invariably was an infiltrate to the adjacent tissue producing a pattern of lobular or mixed panniculitis ( Fig. 5A ). In addition, focally, there was so-called rimming of the atypical lymphocytes around adipocytes, as is seen in panniculitis-like lymphoma. Table 2 summarizes the main histopathologic features and their frequency.
Immunohistochemical Findings
With respect to the perivascular and/or intramural lymphocytes, the cells constantly expressed CD30 and CD8, whereas expression of TIA-1 was variable (Table 3 ) (Figs. 5E-G, 6C, D). However, in cases in which few cells in the angiocentric infiltrates were labeled for CD8, TIA-1 was expressed by a majority of lymphocytes. CD4 was also often expressed by the cells in angiocentric infiltrates, and there was variation with respect to immunoreactivity of CD4 and CD8/TIA-1 even within a single specimen, in the sense that some vessels were surrounded and permeated by predominantly CD8 + elements, whereas in others the reverse was true, or there were equal numbers of CD8 + and CD4 + cells.
With respect to the entire infiltrate, that is both angiocentric and interstitial, an overall predominance of CD8 + cells over CD4 + cells was seen in 8 of 16 cases (50%), whereas the reverse was observed in 4 cases, and the remaining 4 cases showed approximately equal numbers of CD4 + or CD8 + cells in the interstitial infiltrate.
Irrespective of the location (angiocentric vs. interstitial), lymphoid cells were constantly positive for b-F1 and negative for ALK-1 and TCR-d, without loss of CD2 or CD5. There was subtle variation with respect to expression of CD3 and CD7 in the angiocentric infiltrate (Table 3 ). In 1 case (case 4), atypical lymphoid cells in the angiocentric infiltrate were CD56 positive.
In cases with epidermotropism or folliculotropism, intraepithelial lymphocytes coexpressed CD30 and CD8 (Figs. 7B, C).
Molecular Biological Findings
Monoclonal TCR-g gene rearrangements was found in 9 of the 15 cases (60%) studied. In none of the investigated specimens was any viral DNA or RNA detected.
DISCUSSION
Our series of 16 patients describes the clinicopathologic findings of a rare and unusual LyP variant. Because of the predominantly angiocentric and angiodestructive infiltrates of atypical lymphoid cells, rapid development of hemorrhagic necrotic ulcers, and cytotoxic phenotype, this variant simulates aggressive (mostly cytotoxic) lymphomas and may not be recognized as an LPD with an excellent prognosis. With regard to the difference in the histology and clinical presentation to other LyP variants, we propose the designation LyP type E for this disease variant, in addition to well recognized and established types A, B, C, and D. The designation "E" refers not only to the next letter selected to denote this disease variant but also reflects one of the most typical features of the disease, namely eschar-like (hence, type E) ulcers. In its classic form, LyP clinically manifests with crops of papules and small nodules, which may occasionally be accompanied by a small and superficial ulceration preceding spontaneous involution of the lesions. In LyP type E, the initial papular lesions rapidly evolve into larger ulcerations often exceeding the size of the antecedent papule, reaching up to 4 cm in diameter and manifesting a hemorrhagic necrotic, eschar-like appearance. These ulcers persist for 3 to 6 weeks before undergoing spontaneous regression. Because of this predominant ulcerative aspect, in many of our patients the clinical differential diagnosis (before the histopathologic data were available) included pyoderma gangrenosum, ulcerative herpes infection or Orf disease, and vasculitic ulcerations. In many of our patients, only 1 or 2 ulcers at the time of diagnosis and during the disease course were present, whereas in classic LyP usually multiple small papules are found in different stages of lesion evolution. However, 3 patients, at one point of the disease, had also few papules such as those seen in classic LyP, thus rather linking this condition to LyP within the spectrum of cutaneous CD30 + LPD.
From a clinical standpoint our cases are very similar if not identical to the patient described recently by Ponte and colleagues as a borderline CD30 + cutaneous LPD, namely, a presentation with few lesions rapidly becoming ulcers healing with scars. In addition, cytotoxic phenotype was also a feature in that case. 15 However, in contrast to our patients, angiocentric/angiodestructive features were not reported in the histologic specimens by the authors. 15 Histopathologically, LyP types A and C are the most common histopathologic variants with wedgeshaped or nodular infiltrates of large pleomorphic or anaplastic CD30 + lymphoid cells arranged as scattered atypical cells in the background of eosinophils and neutrophils (type A) or in cohesive sheets (type C). The rather uncommon LyP types B and D show an epidermotropic infiltrate of atypical lymphocytes with variable expression of CD30, and both histologically resemble mycosis fungoides and primary cutaneous CD8 + aggressive epidermotropic cytotoxic T-cell lymphoma. In contrast to these 4 histologic types, LyP type E displays a predominantly angioinvasive infiltrate of mostly medium-sized lymphoid cells within the walls of veins and small arterioles in the mid and deep dermis. In the majority of the biopsies, the infiltrates contained numerous eosinophils arranged interstitially or forming small clusters around blood vessels, which, however, were not found within the vessel walls like in the case of leukocytoclastic vasculitides. Particularly in LyP type A, vasculitic changes may be observed, but to a much lesser extent than in our cases in which the angiocentric and angiodestructive growth pattern was the predominant one. The infiltration of the walls of dermal vessels (and sometimes subcutaneous vessels) of different sizes may also explain the clinical features with large ulcers, whereas in other LyP types, occasionally, only small and superficial ulcerations occur on the top of the papules and nodules before they begin to undergo spontaneous regression. Some of our cases manifested infiltration of smooth muscle bundles and perineural spaces by lymphocytes, which may impart a worrisome appearance, inasmuch as this feature is often observed in other lymphomas. However, in recent years it has become increasingly recognized that this feature can also be seen in benign lymphoid proliferations (pseudolymphomas). Parenthetically, the lesion in the above-mentioned case of borderline CD30 + cutaneous LPD displayed this feature as well. [15] [16] [17] [18] A further potentially worrisome finding in our cases was the presence of a dominant T-cell clone in more than half of the examined biopsies. Detection of clonal T cells in LyP varies from 20% to 80% and differs significantly among the various histopathologic forms of LyP. 19 There are only very few reports on LyP cases with an angiocentric pattern, mostly presented as case reports. [20] [21] [22] [23] [24] [25] Generally, they differ from our patients by the clinical features of multiple recurrent papular lesions, whereas our patients showed few hemorrhagic, partly self-healing ulcerations. A single small series of 5 LyP cases with CD8 + cells was reported by Magro and coworkers. 24 Four of their 5 cases were consistent with classic LyP, whereas the fifth case could be identified by the authors as primary cutaneous aggressive epidermotropic CD8 + cytotoxic T-cell lymphoma. 24 The angiocentric infiltrates in LyP in our series displayed mostly a CD8 + cytotoxic phenotype without loss of CD2 or CD5, but there was a slight variation with respect to expression of CD3 and CD7 ( Table 2 ). In some cases, however, in addition to CD8 perivascular and intramural cells there were lymphoid cells expressing CD4, but cells with cytotoxic phenotype dominated in the angiocentric infiltrates. Remarkably, in some cases in which only few atypical lymphocytes expressed CD8, they were immunoreactive for TIA-1. In 1 case, atypical lymphoid cells were CD56 positive. The expression of CD56 by angiocentric infiltrates of LyP has so far been observed in only one case. 25 Expression of CD56 by the CD30 + lymphoid cells is a rare finding in LyP in general and is not associated with impaired prognosis. 26, 27 The histologic findings of angiocentric and angiodestructive infiltrates of atypical lymphocytes and their cytotoxic CD8 + phenotype in most cases of LyP type E may result in interpretation of these cases as highly malignant and aggressive lymphomas. [28] [29] [30] [31] [32] [33] [34] [35] [36] With regard to the low-malignant course with the proclivity of the lesions to undergo spontaneous regression and the excellent prognosis, it is crucial to differentiate this LyP variant from primary cutaneous lymphomas with angiocentric infiltrates and/or a cytotoxic CD8 + or CD56 + phenotype. In the majority of cytotoxic CD8 + cutaneous T-cell lymphomas, the course of the disease is characterized by rapid progression with cutaneous and visceral spread and fatal outcome within months to few years. 37, 38 The course of the disease in our patients does not correspond to the aggressive course observed in most cases of cytotoxic lymphomas. 21, 39, 40 Although all our patients experienced recurrences, in none of the patients did the disease progress to involve extracutaneous sites or cause death.
The differential diagnoses of LyP type E includes extranodal T/NK-cell lymphoma, nasal type, cutaneous g/d-positive T-cell lymphoma, adult T-cell leukemia/ lymphoma, primary cutaneous and systemic anaplastic large cell lymphoma. Extranodal T/NK-cell lymphoma, nasal type, is an aggressive lymphoma with angiocentric and angiodestructive infiltrates of CD3-E + , CD8 +/ À , CD56 + , and necrosis, but in contrast to LyP type E, tumor cells usually lack expression of CD30. [41] [42] [43] A subset of atypical cells express CD30 in extranodal NK/T-cell lymphoma, nasal type, and in other T-cell or NK-cell tumors, but it is rarely expressed by the majority of atypical cells in these neoplasms. Moreover, extranodal NK/T-cell lymphoma, nasal type, is linked to EBV in virtually all cases, whereas none of LyP type E cases was associated with EBV as demonstrated by the absence of EBV assessed by in situ hybridization (Herpes simplex virus-encoded small RNA) and polymerase chain reaction for EBV DNA, respectively. 44, 45 Finally, extranodal NK/ T-cell lymphoma, nasal type, spreads to extracutaneous sites and has a poor prognosis. 46 Cutaneous g/d lymphomas, which may present with angiocentric or subcutaneous infiltrates and ulcers, exhibit a poor prognosis, by definition have to express the g/d chain of the TCR (TCR-d + ), and lack the expression of b-F1 (a/b chain of TCR). 47, 48 In our series of LyP type E, atypical lymphoid cells in all cases stained for this marker expressed b-F1 and were negative for TCR-d thereby excluding cutaneous g/d lymphoma. Other cytotoxic lymphomas such as primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma is a highly aggressive lymphoma with CD8 + epidermotropic infiltrates and numerous necrotic keratinocytes but is consistently CD30 negative. 21 Subcutaneous panniculitis-like T-cell lymphoma and adult T-cell lymphoma/leukemia are excluded as differential diagnosis based on clinical and/or histologic and immunophenotypic findings as well as association with HTLV-1. [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] Secondary cutaneous infiltrates of systemic anaplastic large cell lymphoma (ALCL) were excluded by negative staging examinations.
Another differential diagnostic consideration for cases with mucosal involvement is a recently proposed condition, the so-called mucosal CD30 + lymphoproliferation of the head and neck, which may display a cytotoxic phenotype. 61 Involvement of oral mucosa and lips were much more common in our series than it has been reported in other LyP variants, in which the occurrence of oral LyP lesions is exceedingly rare. In 1 patient in our series, the disease started with oral mucosa involvement.
Like all LyP types, LyP type E shares features with primary cutaneous anaplastic large cell lymphoma and borderline lesions, in which rarely angiocentric infiltrates and CD8 + phenotypes have been reported. [62] [63] [64] This is probably the most challenging differential diagnosis as only a few or even a solitary lesion may be present at a given time, thus seriously limiting application of the general clue of multiple lesions in LyP versus a solitary lesion in ALCL to the distinction between these 2 forms of CD30 + LPDs of the skin. The recurrent lesions are in favor for LyP in our series but this feature may require follow-up. The overlapping features between LyP and primary cutaneous anaplastic large cell lymphoma, however, is emphasized by their categorization as part of the spectrum of CD30 + LPD. 65, 66 The majority of our patients were treated by UV light therapy or topical antiseptics and topical steroids. Low-dose methotrexate to control the disease was used in only 3 patients. Irrespective of the treatment modality used, more than half of the patients experienced complete remission after a median follow-up of 3 years. None of the patients in our series developed a second lymphoid neoplasm as it has been reported to occur in up to 25% of LyP patients, and none of the patients had died due to the disease. 7, [67] [68] [69] [70] In conclusion, we describe a clinically and histologically rare but unique form of LyP clinically characterized by occurrence of a few nodular or papular lesions that rapidly ulcerate and appear as hemorrhagic escharlike ulcers. Histopathologically, a hallmark of the disease is an angioinvasive infiltrate of small to large atypical lymphoid cells with chromatin-dense or moderately chromatin-dense pleomorphic nuclei, expression of CD30 and cytotoxic markers such as CD8 and TIA-1, and necrosis due to destruction of infiltrated vessels. A dominant T-cell clone is found in a majority of the cases. The disease follows an indolent course and has an excellent prognosis, with the lesions manifesting tendency for spontaneous regression and recurrences, a characteristic feature of other forms of LyP, for which we propose a designation LyP type E. This LyP type clinically differs from other classic LyP variants by the absence of multiple papulo-nodular lesions, although few papules similar to those in classic LyP can be observed in rare patients at one point of the disease, thereby indicating the link between this rare form of LyP and its other more common variants. In contrast, the oligolesional manifestation or even occurrence of a single lesion at a certain time point supports the current evidence that LyP and ALCL comprise a spectrum, with borderline lesions. LyP type E differs from ALCL by angiocentric infiltrates of CD30 + CD8 + atypical lymphocytes. Aggressive treatment such as multiagent chemotherapy and bone marrow transplantation, which is often used in highly malignant angiocentric or cytotoxic lymphomas, should be avoided in LyP type E like in other forms of primary cutaneous CD30 + lymphoproliferative disease of the skin. 2 Excision, radiotherapy, and UV light therapy were efficient treatment modalities in our patients.
